The George Washington University
Washington D.C., District of Columbia, 20037, United States
Location status: Recruiting
Location contact
Gulsen Oztosun, M.D.
CONTACT
Henry J Kaminski, M.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07787247
Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating weakness, which can worsen suddenly without a clear predictor. The hypothesis is that continuous monitoring of key aspects of patient physiology and activity coupled to rigorous telemedicine-performed examination has the potential to detect MG worsening which requires change in treatment with the benefit of avoiding need for hospitalization or emergent therapy. This study is to evaluate the reliability of the technology and patient compliance to the monitoring program
Interested in participating?
Request Info18 year and older
All sexes
Observational
Washington D.C., District of Columbia, 20037, United States
Location status: Recruiting
Gulsen Oztosun, M.D.
CONTACT
Henry J Kaminski, M.D.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subject
Exclusion criteria
Disease Specific Exclusion Criteria
Time frame: 12 months
Proportion of subjects complete the 12-month study
Time frame: 12 months
Proportion of assessments provide data sets that can be analyzed
Time frame: 12 months
Proportion of subjects indicate satisfaction with outcome measure assessment
Time frame: 12 months
Correlation of MG-CE individual assessments to MG-ADL assessments
Time frame: 12 months
Correlation of Fitbit metrics to MG-ADL and MG-CE
Time frame: 12 months
Utilizing HADS questionnaire
George Washington University
Other
Pilot Study: Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
Acronym: ROME-MG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07673627
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases
Miami, Florida, United States
View Trial DetailsNCT07761026
AChR Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis
Framingham, Massachusetts, United States
View Trial DetailsNCT07337785
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Wuhan, Hubei, China
View Trial DetailsNCT07526493
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases
Wuhan, Hubei, China
View Trial Details